NBC SECURITIES, INC.

Broker-Dealer

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 791540 BIRMINGHAM, AL

Position in TSHA

as of Mar 31, 2026 · filed Apr 14, 2026 Compact

Position Value

$241,639

-$49,613 QoQ

Shares Held

54,058

+2.1% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#100

of 190 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

NBC SECURITIES, INC. holds $4,320,734 across 55 Biotechnology names. TSHA ranks #6 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	11,280	$729,026
2	REGN	Regeneron Pharmaceuticals, Inc.	436	$336,871
3	AXSM	Axsome Therapeutics, Inc.	1,793	$303,052
4	PTGX	Protagonist Therapeutics, Inc	2,547	$268,453
5	INBX	Inhibrx Biosciences, Inc.	3,800	$255,474
6	TSHA	Taysha Gene Therapies, Inc. This page	54,058	$241,639
7	BBIO	BridgeBio Pharma, Inc.	3,092	$229,611
8	MIRM	Mirum Pharmaceuticals, Inc.	2,420	$223,559

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$241,639	54,058	+2.1%	Shares	Sole	2026-04-14
2025-12-31	$291,252	52,955	—	Shares	Sole	2026-01-29
No filing history on record for this holder in this stock.